< Back to previous page
Researcher
Frédéric Amant
- Disciplines:Gynaecology
Affiliations
- Gynaecological Oncology (Division)
Responsible
From1 Mar 2006 → Today - Gynaecological Oncology (Division)
Member
From1 Jan 2012 → Today
Projects
31 - 40 of 61
- Fulvestrant in gynecological cancers that are potentially hormone sensitive: the FUCHSia studyFrom1 Oct 2018 → 30 Sep 2022Funding: FWO Applied Biomedical Research (TBM)
- Single-cell omics in high throughput and at spatial resolutionFrom1 May 2018 → 30 Apr 2022Funding: FWO Medium Size Research Infrastructure
- Genomic profiling of cell-free DNAFrom12 Oct 2017 → 4 May 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- PROGNOSTIC FACTORS FOR OBSTETRIC AND ONCOLOGICAL OUTCOME IN PREGNANT WOMEN WITH CANCER Chemotherapy in pregnancy: from fetal safety to maternal efficacyFrom20 Sep 2017 → 16 Jun 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Mutated neo-antigens in hepatocellular carcinomaFrom1 Jan 2017 → 31 Dec 2019Funding: FWO research project (including WEAVE projects)
- Unbiased genomic and epigenomic profiling of cell-free plasma DNA for non-invasive cancer screeningFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- Trace, an emerging Belgian Academic PDX platform in translational cancer researchFrom1 Oct 2016 → 30 Sep 2018Funding: Foundations, funds and other with scientific goal
- Cancer and pregnancy: effects of prenatal exposure to cancer treatment on neurocognitive development: an MRI and ERP studyFrom1 Sep 2016 → 30 Sep 2022Funding: FWO fellowships
- Serine auxotrophy: a novel metabolic vulnerability of platinum resistant ovarian cancers?From1 Oct 2015 → 1 Dec 2022Funding: Foundations, funds and other with scientific goal
- Cancer Treatment during pregnancy: from fetal safety to maternal efficacy.From1 Oct 2015 → 31 Mar 2021Funding: H2020-EU.1.3.- EXCELLEN SCIENCE - Marie Skłodowska-Curie actions
Publications
1 - 10 of 584
- Comprehensive Recommendations for the Clinical Management of Pregnant Women With Noninvasive Prenatal Test Results Suspicious of a Maternal Malignancy.(2024)
Authors: Liesbeth Lenaerts, Frédéric Amant, Miel Theunis, Joris Vermeesch
Pages: OP2300594 - Long-term outcomes of children after prenatal exposure to maternal cancer and its treatment(2024)
Authors: Indra Van Assche, Frédéric Amant
- Results of an international survey on the current organization of care for pregnant women with cancer(2024)
Authors: Joosje Heimovaara, Kristel Van Calsteren, Frédéric Amant
- Evaluating offspring Genomic and Epigenomic alterations after prenatal exposure to Cancer treatment In Pregnancy (GE-CIP): a multicentric observational study.(2024)
Authors: Bernard Thienpont, Kristel Van Calsteren, Liesbeth Lenaerts, Frédéric Amant
Pages: e081833 - Sentinel lymph node biopsy for breast cancer during pregnancy: A comprehensive update(2024)
Authors: Frédéric Amant
- ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.(2024)
Authors: Frédéric Amant, Ignace Vergote
Pages: 248 - 266 - Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass.(2024)
Authors: Frédéric Amant
Pages: ijgc-2023- - Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database(2024)
Authors: Joren Vanbraband, Frédéric Amant
Pages: 70 - 78 - Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI(2023)
Authors: Vincent Vandecaveye, Elleke Dresen, Els Van Nieuwenhuysen, Thaïs Baert, Frédéric Amant, Toon Van Gorp
Pages: 1890 - 1897 - Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk(2023)
Authors: Frédéric Amant
Pages: 1931 - 1944